[ad_1]
Take heed to this text
Moon Surgical (Paris and San Francisco) introduced at present that it has raised $31.3 million in Collection A funding to broaden its crew and speed up the event of its Maestro robotic surgical procedure system.
GT Healthcare Capital & Companions led the spherical. There was additionally participation from Johnson & Johnson Innovation – JJDC, Cathay Well being — and present buyers together with Sofinnova Companions and medtech leaders together with Yann Fleureau, Siddarth Satish, Sacha Loiseau and Richard Leparmentier.
“At Moon Surgical, our ambition is to revolutionize minimally invasive surgical procedure by the facility of collaborative and adaptive robotics. Our Maestro System can be utilized in any laparoscopy, in any working room,” mentioned Anne Osdoit, CEO of Moon Surgical and a associate in Sofinnova Companions’ medtech accelerator, MD Begin.
“We’re excited to work with our new companions at GT Healthcare, Johnson & Johnson, and Cathay Well being as we enter the following stage of our firm’s evolution,” Osdoit mentioned in a information launch.
The 2-year-old firm mentioned it has early absolutely purposeful methods and pushed by greater than 30 surgeons throughout two continents and a number of medical indications. The corporate’s objective behind Maestro is to have a system that’s small, adaptable and built-in into present medical workflows.
“We share the imaginative and prescient of Maestro’s data-driven capabilities in underserved laparoscopic procedures, and hope to help its path in making robotic surgical procedure accessible throughout all geographies,” mentioned Alan Au, managing associate of GT Healthcare. He’s becoming a member of Moon Surgical’s board.
Dr. Steve Oesterle, a former Medtronic SVP and enterprise associate at Cathay Well being, mentioned Maestro is about democratizing management throughout surgical procedure. “We’re all very desperate to help this international enterprise in its improvement in order that it may quickly be utilized in many surgical procedures.”
Oesterle and Intuitive co-founder Dr. Fred Moll, chief improvement officer of J&J’s Auris Well being, will function Moon Surgical board advisors.
[ad_2]